Is It a True Drug Allergy?

Nearly 90% of people who say they have a penicillin allergy, don’t have a true allergy. And it often leads to a prescription for a more expensive and less effective medication. In this course, you’ll learn a guideline-based approach to evaluating and discussing hypersensitivity in patients with documented allergies, opening up their drug therapy options.

Upon successful completion of this application-based CPE course, pharmacists should be able to:
1. Review the pathophysiology and clinical presentation of drug hypersensitivity reactions
2. Recognize different methods of evaluating drug hypersensitivity reactions
3. Develop a guideline-based management plan for a patient with history of antibiotic allergy
4. Summarize the guideline-based approach to patients with NSAID, chemotherapy, and biologic agent allergies

Sarah Withers, PharmD, MS, BCIDP
Pharmacy Specialist
Prisma Health

Dr. Withers has no relevant financial relationships with ineligible companies to disclose.

Course fee includes course, course materials, and CPE credit submission to CPE Monitor.
Course is non-refundable.
Initial Release Date: July 1, 2023
Planned Expiration Date: July 1, 2026

RV1-4.24

Universal Activity Number (UAN): 0107-0000-23-199-H01-P

Application-based CPE Activity

CEImpact is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Obtain CPE credit by completing the course, followed by the exam and evaluation (if applicable). Once successfully completed, your course will appear in your Completed Courses tab. Access your CPE statement of credit at www.MyCPEMonitor.net.

¹CEImpact provides you with two (2) opportunities to complete the exam. The learner will not receive CPE credit after two failed attempts.

Additional information

Duration	1h 0m
Topic Designator	Disease State/Drug Therapy
ACPE	Yes
ACPE Topic	01 Drug Therapy
Role	Pharmacist
Media-Type	On-Demand
Release Date	7/1/23
CEUs	0.1
Rating	4
ACPE Number	0107-0000-23-199-H01-P